Company Filing History:
Years Active: 2016-2025
Title: Chih-Yung Hu: Innovator in Antibody Therapeutics
Introduction
Chih-Yung Hu is a distinguished inventor based in New Taipei, Taiwan, known for his significant contributions to the field of biotechnology. With a portfolio of five patents, his work focuses on innovative approaches to antibody therapies, particularly in addressing cancer treatments.
Latest Patents
Among his latest patents, Hu has developed groundbreaking inventions including:
1. **Anti-CD73 antibodies and use thereof** - This invention pertains to a novel antibody that specifically binds to human CD73 at precise epitopes. The antibody and its antigen-binding fragments have been designed with specific complementarity-determining regions (CDRs), enhancing their therapeutic potential.
2. **Humanized antibodies against Globo H and uses thereof in cancer treatments** - This patent details a humanized anti-Globo H antibody, structured with specific heavy-chain and light-chain variable domains. The sequences of various complementary regions have been meticulously outlined, showcasing their role in fostering new treatment avenues for cancer.
Career Highlights
Chih-Yung Hu has made substantial advancements in antibody research while working with reputable organizations such as the Development Center for Biotechnology and DCB-USA LLC. His career is marked by a commitment to harnessing the power of antibodies to tackle pressing health challenges.
Collaborations
Throughout his career, Hu has collaborated with esteemed colleagues, including Ying-Yung Lok and Szu-Liang Lai. Their teamwork has contributed to the successful development of various innovative therapeutic solutions, leveraging their combined expertise in biotechnology.
Conclusion
Chih-Yung Hu exemplifies the spirit of innovation in the field of antibody therapeutics. His patents reflect a dedication to advancing medical science and improving cancer treatment methodologies. As he continues his work, his contributions will undoubtedly play a vital role in the ongoing fight against cancer and other diseases.